Product Information

FELBAMATE 400 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.7265 per EA under NDC 51672418501. Its NADAC has been published 454 times since Dec 13, 2017.

FDA first approved this application on Apr 20, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FELBAMATE 400 MG TABLET

Felbamate
$0.7265per EA

Strength

400 mg/1

NDC

51672418501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FELBAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207093

FDA Approved

4/20/2017

TE Code

AB

On Market Since

4/20/2017

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for FELBAMATE 400 MG TABLET has been published 454 times since Dec 13, 2017, and over the history we have for it it has declined 78.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7265 per EA
All-time high$3.2983 (Dec 13, 2017)
All-time low$0.6785 (Jul 22, 2026)
52-week high$1.0316
52-week low$0.6785
Median price$1.2919
Average price$1.7432
Largest weekly change-59.2% (Oct 21, 2020)
Weeks tracked454
Tracking sinceDec 13, 2017

Price History

1W

+7.1%

1M

+7.1%

3M

-9.9%

6M

-28.7%

1Y

-17.6%

3Y

-26.6%

5Y

-60.2%

All

-78.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FELBAMATE 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 400 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.7265 per EA (NDC 51672418501), effective Aug 19, 2026.

How has the price of FELBAMATE 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for FELBAMATE 400 MG TABLET has declined 78.0%. It has been tracked across 454 weekly CMS publications since Dec 13, 2017.

What are the highest and lowest recorded NADAC prices for FELBAMATE 400 MG TABLET?

Since Dec 13, 2017, the NADAC for FELBAMATE 400 MG TABLET has ranged from a low of $0.6785 (Jul 22, 2026) to a high of $3.2983 (Dec 13, 2017), with a median of $1.2919 per EA.

Are there cheaper alternatives to FELBAMATE 400 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FELBAMATE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FELBAMATE 400 MG TABLET?

FELBAMATE 400 MG TABLET (NDC 51672418501) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.